Clinical Trial Update: Rosiglitazone in Treating Patients With Newly Diagnosed ACTH-Secreting Pituitary Tumor (Cushing Disease) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial investigating rosiglitazone for newly diagnosed ACTH-secreting pituitary tumors (Cushing disease) was terminated with results posted in 2…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cushing Disease

Drugs mentioned

• Rosiglitazone (rosiglitazone)

Snippet

Sponsor: Jonsson Comprehensive Cancer Center | Conditions: Cushing's Disease | Phase 2 | Status: TERMINATED | Results posted: 2016-02-17